Those at highest risk for severe COVID-19 often least likely to get monoclonal antibodies
People over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs)—a highly effective treatment for the disease—both across and within U.S. states, according ...
Feb 4, 2022
0
101